Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,089–4,096 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Traws Pharma Inc Com par $0.01 (New) Rigosertib Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma Phase 2 Trial Completed Oral or intravenous Oncology
Traws Pharma Inc. Rigosertib plus the PD-1 inhibitor pembrolizumab (Oral) Melanoma Phase 2 Ongoing Oral Oncology
Traws Pharma Inc. Ratutrelvir COVID-19 Phase 2 Data Released Oral COVID-19
Traws Pharma Inc. Tivoxavir Marboxil H5N1 avian influenza Phase 2 Trial Planned Oral Antiviral
Traws Pharma Inc. Rigosertib Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma Phase 2 Trial Completed Oral or intravenous Oncology
Trevena Inc. TRV027 COVID-19 Phase 2/3 Trial Discontinued Intravenous COVID-19
Trevena Inc. TRV734 Opioid use disorder Phase 2 Trial Discontinued oral Anti-Addiction
Trevena Inc. TRV027 - BLAST-AHF Acute heart failure Phase 2a Trial Discontinued Intravenous Cardiology